Administration of bisphosphonate for hypercalcemia associated with oral cancer

被引:2
作者
Kojiro Onizawa
Hiroshi Yoshida
机构
[1] University of Tsukuba,Oral and Maxillofacial Surgery, Doctoral Program in Functional and Regulatory Medical Sciences, Graduate School of Comprehensive Human Sciences
关键词
Oral Cancer; Hypercalcemia; Pamidronate; Oral Cancer Patient; Humoral Hypercalcemia;
D O I
10.1186/1746-160X-2-9
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[1]  
Yamazaki H(2000)Hypercalcemia in patients with oral cancer Head and Neck Cancer 26 95-100
[2]  
Ota Y(2004)Medical management of hypercalcemia Calcif Tissue Int 74 1-11
[3]  
Karakida K(1990)Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients Ann Intern Med 112 499-504
[4]  
Sekiya R(2001)Hypercalcaemia of malignancy: an undiagnosed and undertreated disease J Intern Med 250 73-79
[5]  
Mizusawa N(2002)Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer 10 399-407
[6]  
Goto J(2003)Hypercalcemic complication in patients with oral squamous cell carcinoma Int J Oral Maxillofac Srg 32 174-180
[7]  
Arai I(1973)Interpretation of serum calcium in patients with abnormal serum proteins Br Med J 4 643-646
[8]  
Nohara T(1999)Treatment of malignancy-associated hypercalcemia by bisphosphonates Clinical Calcium 9 1415-1419
[9]  
Watanabe D(1989)Hypercalcemia in malignancy. Fluids and Bisphosphonate are best when life is threatened Br Med J 298 1468-1469
[10]  
Aoki T(1995)Analysis of survival following treatment of tumor-induced hypercalcaemia with intravenous pamidronate (APD) Br J Cancer 72 206-209